Marker Therapeutics Inc (MRKR)

[learningcurve2020]

Is this an accurate statement when trials cost $100M these days?

>>Paying Marker approximately $19 million in cash and simultaneously eliminating about $11 million of Marker’s annual costs related to its personnel and facilities, greatly reduces Marker’s cash needs as it pursues clinical development of its lead programs.